Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001209191-22-003051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-12 | 2022-01-10 | FATE | TAHL CINDY | GC, Sec | S - Sale | $46.43 | -7,738 | 161.9K | -5% | -$359.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | S | D | 643 | $47.15 | 161,268 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $46.97 to $47.42 per share. |
| 2 | Common | Common Stock | 2022-01-10 | S | D | 7,095 | $46.37 | 161,911 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $45.71 to $46.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3. |